We use cookies to make it easier for you to use our website and give you a better experience. We aggregate the information we get through cookies from users like you, and analyze that data to better understand user behavior and help us improve the website. We do not give or sell the data you provide through cookies to any third party for any purpose (such as advertising or marketing). By using this website, you consent to Organogenesis using cookies for these purposes. You may change your settings anytime by clicking on the “Security” tab on your browser. Note that Organogenesis is located in the United States, and the U.S. has not yet been determined to have “adequate” data privacy safeguards by the EU; despite any inherent risks in the transfer of data from the EU, Organogenesis takes the security of your information seriously. To read our privacy policy, click here.

Customer Service

Company Profile

Organogenesis Inc.

A leading tissue regeneration company with the unique skill set to take complex, living therapies from R&D, through manufacturing, to successful commercialization.


To bring the medical marvel of tissue regeneration to patients and to standardize its use in everyday medical care.



Head Office
150 Dan Road
Canton, Massachusetts
Google Map

General telephone number: (781)575-0775

Major Milestones

1998: First FDA approval of a living, allogeneic, cell based product (Apligraf® approved for the treatment of venous leg ulcers.)
2000: Apligraf® FDA approved for the treatment of diabetic foot ulcers.
2004: Launch of full USA national sales and marketing organization.
2005: Over 100,000 patients treated with a living, cell based therapy.


Over 200 employees in USA
2006 expansion to Switzerland

Areas of Focus
Three pillars:
  • Bio-active wound healing
  • Bio-aesthetics
  • Bio-surgery™
Key Pipeline Products

Multiple brands in active development in each of our three pillars of business.